中國鐵鈦(00893.HK):建行展開針對會理財通的訴訟 涉及貸款本金2.769億元
格隆匯3月28日丨中國鐵鈦(00893.HK)發佈公吿,公司於2024年3月27日獲吿知,中國建設銀行涼山分行(“建行”)於中國展開針對公司前間接全資子公司會理市財通鐵鈦有限責任公司(“會理財通”)的訴訟,涉及會理財通於建行的貸款本金人民幣2.769億元及其利息(會理財通仍在核實及確認相關計算),而公司於2019年出售會理財通及其子公司(“會理財通集團”)前一直就此提供公司擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.